GMO

since 1977
  • 201-500 employees
  • Investment Management

GMO

For more than 40 years, GMO has partnered with a broad range of sophisticated institutions, financial intermediaries, and families to provide the investment expertise they need to meet their goals and fulfill their missions.

Investing on behalf of our clients is GMO’s sole focus. Across asset classes and around the world, our investment teams identify and exploit long-term opportunities and develop solutions that both anticipate and respond to client needs.

GMO is comprised of a collection of investment teams with focused specialties. All are grounded in a long-term, valuation-based investment philosophy – an approach we believe provides the best risk-adjusted returns.

GMO partners with an impressive roster of sophisticated clients worldwide, delivering innovative investment solutions and tailored client service. Our clients benefit from our diverse expertise, intellectual curiosity, and open culture of debate, as well as from our ability and willingness to take advantage of contrarian market opportunities.

For important disclosure information please visit: https://www.gmo.com/americas/terms-and-conditions/

10 TAKEAWAYS FROM THE PAST THREE YEARS
  • 02 Apr 2026

After three years of live results, small-cap quality proved resilient. Lessons on tracking error, earnings growth, junk rallies, and why disciplined research matters more in small caps now.

GAINS WITHOUT PAINS
  • 30 Mar 2026

How GMO Dynamic Allocation (GMOD) helps with reallocating a balanced portfolio (without the tax drag).

BEYOND 60/40: FOUR OPPORTUNITIES TO IMPROVE E...
  • 26 Mar 2026

Investors interested in enhancing diversification and future returns may want to consider four valuation-driven opportunities the GMO Asset Allocation team has uncovered.

SINK OR SWIM
  • 20 Mar 2026

AI capex is surging. Yet, history shows investment booms often precede recessions and lower equity returns across most developed markets.

GMO 7-YEAR ASSET CLASS FORECAST: FEBRUARY 202...
  • 16 Mar 2026

GMO's 7-Year Asset Class Forecast as of February 29, 2024.

THE PRICE OF HAVING FUN
  • 16 Mar 2026

GMO’s Asset Allocation team discusses the lottery like appeal of growth stocks, how it often leads to lower returns, and why today’s valuations favor value.

YEAR-END LETTER FOR 2025: DEEP VALUE
  • 12 Mar 2026

In this year-end letter, John Thorndike, Warren Chiang, and George Sakoulis discuss GMOV and GMOI results for 2025 and their outlook for 2026.

WHEN THE UPSIDE IS THIN, UPGRADE THE CARRY
  • 10 Mar 2026

GMO’s Structured Products team explores how high quality structured credit can improve carry, reduce spread risk, and strengthen downside protection when spreads are tight.

HYPE VS HIGH CONVICTION
  • 04 Mar 2026

For investors, the real opportunity in investing in AI lies in distinguishing between companies with durable competitive advantages and those exposed to the boom-and-bust cycle.